• Info
  • Insider Ownership

Insider Trading & Ownership of Fred E. Cohen

Location
Fort Worth, TX
Summary
The estimated net worth of Fred E. Cohen is at least $13.6M dollars as of 17 Jun 2025. Fred E. Cohen is the Director, 10%+ Owner of Kyverna Therapeutics, Inc. and owns shares of Kyverna Therapeutics, Inc. (KYTX) stock worth about $9.58M. Fred E. Cohen is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $2.81M. Fred E. Cohen is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $725K. Fred E. Cohen is the Director of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $478K.
Signature
/s/ Fred E. Cohen
All Insider Reports
All Insider Reports

Notify me when Fred E. Cohen files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Fred E. Cohen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KYTX Kyverna Therapeutics, Inc. Director, 10%+ Owner $9.58M 29 May 2025
CDNA CareDx, Inc. Director $2.81M 13 Jun 2025
PGNY Progyny, Inc. Director $725K 23 May 2024
NTLA Intellia Therapeutics, Inc. Director $478K 11 Jun 2025
URGN UroGen Pharma Ltd. Director 06 Aug 2024

Insider Transactions Reported by Fred E. Cohen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.